down arrow

Apogee Therapeutics, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03770N1019
USD
75.50
6.37 (9.21%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Apogee Therapeutics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
No of Months
12
12
12
Profit Before Tax
-182.00
-83.00
-39.00
Adjustment
0.00
0.00
0.00
Changes In working Capital
-2.00
6.00
9.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
Cash Flow from Operating Activities
-171.00
-74.00
-16.00
Cash Flow from Investing Activities
-300.00
-273.00
0.00
Cash Flow from Financing Activities
495.00
315.00
168.00
Net Cash Inflow / Outflow
23.00
-33.00
151.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Apogee Therapeutics, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-182.128
-239.724
57.00
24.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2.002
15.348
-17.00
-113.04%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-171.174
-193.309
22.00
11.45%
Cash Flow from Investing Activities
-300.462
-4.593
-296.00
-6441.74%
Cash Flow from Financing Activities
495.109
201.961
294.00
145.15%
Net Cash Inflow / Outflow
23.473
4.059
19.00
478.30%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -128.96% vs -355.11% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-171.17
-74.76
-128.96%

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."